EURACTIV PR

An easy way of publishing your relevant EU press releases.

Medicines for Europe

Press Releases of this organisation

TITLEsort descending ORGANISATION DATE TOPIC
Harmonised bioequivalence guideline paves the way for global generic medicine development and access to medicines Medicines for Europe 26 Apr 2023 Health & Consumers
Health at a Glance Report highlights public value of generic, biosimilar and value added medicines Medicines for Europe 26 Nov 2018 Health & Consumers
HERA must address outstanding weaknesses in EU pharma framework to be successful Medicines for Europe 16 Sep 2021 Health & Consumers
IGBA congratulates the Australian Government for maintaining their Biologics Naming Convention and for strengthening pharmacovigilance Medicines for Europe 29 Jan 2018 Health & Consumers
IGBA launches a Biosimilar Medicines Information Campaign Medicines for Europe 01 Feb 2018 Health & Consumers
Immediately calls on new President of EU Commission to prioritise Healthcare Medicines for Europe 25 Sep 2019 Health & Consumers, InfoSociety
IQVIA Institute Scorecards show biosimilar medicines offer win for patients, policymakers and healthcare systems across Europe Medicines for Europe 30 Jun 2020 Health & Consumers
Latest Data Shows the Need to Promote Biosimilar and Value Added Medicines for Better Health Medicines for Europe 16 Jun 2017 Health & Consumers
Market reforms needed to secure essential antibiotics against AMR, report says Medicines for Europe 16 Feb 2023 Health & Consumers
Medicines for Europe announces new President, launches Access to Medicines campaign Medicines for Europe 10 Oct 2017 Health & Consumers
Medicines for Europe calls for greater cooperation on value added medicines to improve patient-centric innovation Medicines for Europe 22 Nov 2017 Health & Consumers
Medicines for Europe can contribute much more to improve healthcare sustainability than described in the OECD “Health at a Glance 2016” report Medicines for Europe 24 Nov 2016 Health & Consumers
Medicines for Europe joins the Antimicrobial (AMR) One Health Network Medicines for Europe 09 May 2023 Health & Consumers
Medicines for Europe members publish disclosure of Transfers of Value to the healthcare community Medicines for Europe 22 Jun 2018 Health & Consumers
Medicines for Europe statement on COVID-19 (‘coronavirus’) Medicines for Europe 13 Mar 2020 Health & Consumers
Medicines for Europe to join the ISPOR Issue Panel on value added medicines Medicines for Europe 05 Oct 2017 Health & Consumers
Medicines for Europe warns strongly against energy rationing for medicines production Medicines for Europe 20 Jul 2022 Health & Consumers
Medicines for Europe welcomes Competitiveness Council discussion to stop delocalisation of medicine manufacturing. It is time to effectively position Europe as a global hub for the production of medicines. Medicines for Europe 30 Nov 2018 Health & Consumers
Medicines for Europe, APOGEN and Fresenius Kabi hold Open Industry Day in Portugal Medicines for Europe 14 Nov 2019 Health & Consumers
New report assesses progress on biosimilar medicine policies across Europe Medicines for Europe 30 Mar 2021 Health & Consumers
New report reveals need for pricing and reimbursement and procurement reforms to ensure patient access and healthcare sustainability Medicines for Europe 01 Mar 2021 Health & Consumers
New safeguards for patient safety as Falsified Medicines Directive comes into force Medicines for Europe 11 Feb 2019 Health & Consumers
No further excuse to delay digital regulatory infrastructure for medicines after COVID-19 pandemic Medicines for Europe 19 Feb 2021 Health & Consumers
Now or never: pragmatism & ambition needed in EU pharma strategy to deliver on Europe’s medicines manufacturing Medicines for Europe 07 Oct 2020 Health & Consumers
Off patent medicines essential for a fairer, healthier, and sustainable Europe says President Christoph Stoller Medicines for Europe 30 Apr 2021 Health & Consumers
Oncology, the new era for biosimilar medicines Medicines for Europe 08 Sep 2017 Health & Consumers
Open borders that prioritise essential goods key to medicines supply in Europe Medicines for Europe 02 Jun 2021 Health & Consumers
Orphan and paediatric reform should strive to improve access to medicine for rare disease patients and children Medicines for Europe 30 Jul 2021 Health & Consumers
Parliament’s Health Committee (ENVI) introduces constructive amendments to SPC Manufacturing waiver vote in its official opinion to the Parliament’s Legal Committee (JURI). Medicines for Europe 28 Nov 2018 Health & Consumers
Parliament’s Trade Committee votes for jobs and access to medicines with a comprehensive SPC Manufacturing Waiver! Medicines for Europe 04 Dec 2018 Health & Consumers

Pages